• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

ATL loses appeal on SRI lawsuit

Article

ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a

ATL Ultrasound announced last month that the U.S. Court of Appeals affirmed a lower court decision in the patent litigation filed against the Bothell, WA-based vendor by SRI International. ATL does not plan to appeal further, which brings the case to a close. The company has already set aside $37.1 million in prior financial periods to cover the full cost of the judgment, which was awarded in 1996 (SCAN 6/5/96). SRI filed the suit in 1991, charging ATL with violating a patent SRI received in 1977 for tracking filter circuits used in ATL's Ultramark 4, Ultramark 5, and ADR 4000 ultrasound scanners, all of which have been discontinued. The relevant patent expired in 1994, according to ATL.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.